Investing.com - Amedisys (NASDAQ:AMED) reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Amedisys announced earnings per share of $0.79 on revenue of $558.00. Analysts polled by Investing.com anticipated EPS of $1.22 on revenue of $580.28M.
Amedisys shares are down 39% from the beginning of the year, still down 48.31% from its 52 week high of $188.88 set on November 9, 2021.
Amedisys follows other major Healthcare sector earnings this month
Amedisys's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar